Science & health
Guinea-Bissau police seize vaccines amid dispute over newborn hepatitis B trial
Judicial police in Guinea-Bissau seized hepatitis B vaccine doses from researchers whose proposed trial would withhold birth vaccination from 7,000 newborns during their first six weeks. The researchers secured ethics approvals, but Guinea-Bissau’s health minister disputes claims that the study will proceed, while the WHO calls withholding the vaccine unethical and dangerous. The report also examines the project’s financing, its researchers’ influence on US vaccine debates and criticism of Guinea-Bissau’s fragile research infrastructure.
Editorial summary · Publisher article
What matters
- Police said the seizure was intended to clarify circumstances surrounding the vaccine batch, not to indicate proven problems with quality, safety or effectiveness.
- The redesigned study would still deny newborns a vaccine that is highly effective when given within 24 hours of birth.
- The project received $3.2m from US and philanthropic funders, and its researchers have been publicly praised by Robert F Kennedy Jr.
Why the trial is contested
The WHO says birth vaccination is an essential intervention and warns that withholding it could expose newborns to serious, irreversible harm. Guinea-Bissau’s government has also challenged claims that the trial is moving forward.
Context & caveats
- The account relies partly on translated official social-media material and outside criticism; the researchers did not respond to the newspaper’s questions.
Why this made the edition
Substantive reporting documents a police seizure, contested clinical-trial ethics, official disagreement and the researchers’ links to US vaccine-policy debates.
Source material